April 2, 2024
Now available ZYMFENTRA™
ZYMFENTRA® (infliximab-dyyb) injection is a tumor necrosis factor (TNF) blocker indicated in adults for maintenance treatment of:
-moderately to severely active ulcerative colitis following treatment with an infliximab product administered intravenously.
-moderately to severely active Crohn’s disease following treatment with an infliximab product administered intravenously.
Please see full prescribing information.